Announcements Trials
Browse Landscape

Phase

Phase 3 2

Status

Terminated 1Completed 1

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Classical hematology 2

Conditions

Neoplasms 3Venous Thrombosis 2Venous Thromboembolism 2Thrombosis 1Pulmonary Embolism 1Hemorrhage 1

Interventions

Dalteparin 8apixaban 6Rivaroxaban 6Heparin, Low-Molecular-Weight 5Tinzaparin 4Enoxaparin 4bemiparin 2abelacimab 2Warfarin 2MAA868 2Aspirin 2reviparin 1isoquercitrin 1edoxaban 1certoparin 1betrixaban 1argatroban 1acarboxyprothrombin 1Phenprocoumon 1Nadroparin 1N(4)-oleylcytosine arabinoside 1Dabigatran 1Acenocoumarol 1AVE 5026 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 3 × Venous Thromboembolism × bemiparin × Clear all
NCT01164046 2014-12-03

Longheva

University Medical Center Groningen

Phase 3 Terminated
56 enrolled
Classical hematology

Neoplasms, Venous Thrombosis, Venous Thromboembolism

NCT00219973 2010-04-28

CANBESURE STUDY (Cancer, Bemiparin and Surgery Evaluation)

Rovi Pharmaceuticals Laboratories

Phase 3 Completed
526 enrolled
Classical hematology

Hemorrhage, Neoplasms, Pulmonary Embolism, Venous Thrombosis, Venous Thromboembolism

Data powered by HemOnc (CC BY 4.0) Colophon âš¡